New, minimally invasive biomarker-based strategy 90% successful in detecting esophageal cancer
In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally invasive biomarker-based strategy they developed was 90% successful in detecting esophageal squamous cell carcinoma (ESCC), the predominant subtype of esophageal cancer worldwide.
United States Johns Hopkins University Johns Hopkins Hospital National Institutes Of Health Mbarara District Mouena Khashab
Source: news-medical.net